Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FES BPET/DBT in Primary Breast Cancer
NCT05659797Phase 1Recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Oct 2023
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Abramson Cancer Center. Primary endpoints: Uptake of FES on BPET at 6 weeks, Image quality at 6 weeks and 3 more. Started Oct 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05659797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05659797.